IBDEI2RY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46577,1,3,0)
 ;;=3^Cutaneous Cryptococcosis
 ;;^UTILITY(U,$J,358.3,46577,1,4,0)
 ;;=4^B45.2
 ;;^UTILITY(U,$J,358.3,46577,2)
 ;;=^5000671
 ;;^UTILITY(U,$J,358.3,46578,0)
 ;;=B44.7^^206^2304^56
 ;;^UTILITY(U,$J,358.3,46578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46578,1,3,0)
 ;;=3^Disseminated Aspergillosis
 ;;^UTILITY(U,$J,358.3,46578,1,4,0)
 ;;=4^B44.7
 ;;^UTILITY(U,$J,358.3,46578,2)
 ;;=^5000666
 ;;^UTILITY(U,$J,358.3,46579,0)
 ;;=B45.7^^206^2304^57
 ;;^UTILITY(U,$J,358.3,46579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46579,1,3,0)
 ;;=3^Disseminated Cryptococcosis
 ;;^UTILITY(U,$J,358.3,46579,1,4,0)
 ;;=4^B45.7
 ;;^UTILITY(U,$J,358.3,46579,2)
 ;;=^5000673
 ;;^UTILITY(U,$J,358.3,46580,0)
 ;;=B39.9^^206^2304^59
 ;;^UTILITY(U,$J,358.3,46580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46580,1,3,0)
 ;;=3^Histoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,46580,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,46580,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,46581,0)
 ;;=J18.2^^206^2304^60
 ;;^UTILITY(U,$J,358.3,46581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46581,1,3,0)
 ;;=3^Hypostatic Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,46581,1,4,0)
 ;;=4^J18.2
 ;;^UTILITY(U,$J,358.3,46581,2)
 ;;=^5008184
 ;;^UTILITY(U,$J,358.3,46582,0)
 ;;=B44.0^^206^2304^61
 ;;^UTILITY(U,$J,358.3,46582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46582,1,3,0)
 ;;=3^Invasive Pulmonary Aspergillosis
 ;;^UTILITY(U,$J,358.3,46582,1,4,0)
 ;;=4^B44.0
 ;;^UTILITY(U,$J,358.3,46582,2)
 ;;=^5000663
 ;;^UTILITY(U,$J,358.3,46583,0)
 ;;=J18.1^^206^2304^62
 ;;^UTILITY(U,$J,358.3,46583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46583,1,3,0)
 ;;=3^Lobar Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,46583,1,4,0)
 ;;=4^J18.1
 ;;^UTILITY(U,$J,358.3,46583,2)
 ;;=^5008183
 ;;^UTILITY(U,$J,358.3,46584,0)
 ;;=A19.9^^206^2304^63
 ;;^UTILITY(U,$J,358.3,46584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46584,1,3,0)
 ;;=3^Miliary Tuberculosis,Unspec
 ;;^UTILITY(U,$J,358.3,46584,1,4,0)
 ;;=4^A19.9
 ;;^UTILITY(U,$J,358.3,46584,2)
 ;;=^5000104
 ;;^UTILITY(U,$J,358.3,46585,0)
 ;;=R76.11^^206^2304^82
 ;;^UTILITY(U,$J,358.3,46585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46585,1,3,0)
 ;;=3^Reaction to Skin Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,46585,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,46585,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,46586,0)
 ;;=B45.3^^206^2304^67
 ;;^UTILITY(U,$J,358.3,46586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46586,1,3,0)
 ;;=3^Osseous Cryptococcosis
 ;;^UTILITY(U,$J,358.3,46586,1,4,0)
 ;;=4^B45.3
 ;;^UTILITY(U,$J,358.3,46586,2)
 ;;=^5000672
 ;;^UTILITY(U,$J,358.3,46587,0)
 ;;=B44.89^^206^2304^44
 ;;^UTILITY(U,$J,358.3,46587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46587,1,3,0)
 ;;=3^Aspergillosis NEC
 ;;^UTILITY(U,$J,358.3,46587,1,4,0)
 ;;=4^B44.89
 ;;^UTILITY(U,$J,358.3,46587,2)
 ;;=^5000667
 ;;^UTILITY(U,$J,358.3,46588,0)
 ;;=B45.8^^206^2304^53
 ;;^UTILITY(U,$J,358.3,46588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46588,1,3,0)
 ;;=3^Cryptococcosis NEC
 ;;^UTILITY(U,$J,358.3,46588,1,4,0)
 ;;=4^B45.8
 ;;^UTILITY(U,$J,358.3,46588,2)
 ;;=^5000674
 ;;^UTILITY(U,$J,358.3,46589,0)
 ;;=H60.593^^206^2304^64
 ;;^UTILITY(U,$J,358.3,46589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46589,1,3,0)
 ;;=3^Noninfective AC Otitis Externa,Bilateral NEC
 ;;^UTILITY(U,$J,358.3,46589,1,4,0)
 ;;=4^H60.593
 ;;^UTILITY(U,$J,358.3,46589,2)
 ;;=^5006491
 ;;^UTILITY(U,$J,358.3,46590,0)
 ;;=H60.592^^206^2304^65
 ;;^UTILITY(U,$J,358.3,46590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46590,1,3,0)
 ;;=3^Noninfective AC Otitis Externa,Left Ear NEC
